Precision BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	99.37	110.82	85.9	116.68	189.58	143.66
Short-Term Investments	1.81	4.76	0.41	-	-	-
Cash & Short-Term Investments	101.18	115.59	86.31	116.68	189.58	143.66
Cash Growth	31.03%	33.91%	-26.02%	-38.45%	31.96%	59.98%
Accounts Receivable	4	-	0.23	0.9	0.72	0.49
Other Receivables	-	-	1.47	11.9	-	-
Total Trade Receivables	4	-	1.7	12.8	0.72	0.49
Other Current Assets	3.51	3.16	6.98	6.88	8.81	17.6
Total Current Assets	108.69	118.74	94.99	136.36	199.11	161.75
Net Property, Plant & Equipment	6.65	7.23	10.18	8.26	13.78	29.33
Other Intangible Assets	1.13	1.17	0.62	0.4	0.73	2.05
Long-Term Investments	0.74	0.74	7.81	8.2	11.98	13.72
Other Long-Term Assets	26.68	26.54	22.79	6.56	12.57	4.64
Total Assets	143.89	154.42	136.39	159.78	238.17	211.5
Accounts Payable	0.94	0.3	1.31	2.97	0.65	1.14
Accrued Expenses	4.4	6.46	7.2	6.54	6.93	10.79
Current Portion of Long-Term Debt	-	-	-	22.41	-	-
Current Portion of Leases	1.56	1.51	1.32	1.13	1.68	1.82
Unearned Revenue	-	-	2.96	12.04	46.19	21.24
Other Current Liabilities	0.86	0.65	2.19	4.9	4.21	0.98
Total Current Liabilities	7.76	8.91	14.98	49.99	59.66	35.98
Long-Term Debt	22.42	22.4	22.32	-	22.22	2.48
Long-Term Leases	4.49	4.9	6.4	7.72	1.06	4.81
Other Long-Term Liabilities	33.13	25.95	36.29	83.21	94.79	77.06
Total Long-Term Liabilities	60.04	53.26	65.02	90.93	118.07	84.35
Total Liabilities	67.79	62.17	80	140.92	177.74	120.33
Common Stock	0	0	0	0	0	-
Treasury Stock	-0.95	-0.95	-0.95	-0.95	-0.95	-0.95
Additional Paid-in Capital	623.68	621.39	539.81	509.44	489.7	408.8
Retained Earnings	-546.63	-528.19	-482.46	-489.63	-428.31	-316.68
Shareholders' Equity	76.1	92.25	56.39	18.86	60.43	91.17
Total Liabilities & Equity	143.89	154.42	136.39	159.78	238.17	211.5
Total Debt	28.47	28.81	30.05	31.27	24.96	9.11
Net Cash (Debt)	72.72	86.78	56.27	85.41	164.62	134.55
Net Cash Growth	-16.20%	54.22%	-34.12%	-48.12%	22.35%	69.72%
Net Cash Per Share	4.36	6.77	8.17	22.23	56.19	68.78
Book Value	76.1	92.25	56.39	18.86	60.43	91.17
Book Value Per Share	4.57	7.19	8.19	4.91	20.63	46.60
Tangible Book Value	74.97	91.08	55.77	18.46	59.7	89.12
Tangible Book Value Per Share	4.50	7.10	8.10	4.81	20.38	45.56

SEC Filings: 10-K · 10-Q